Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 11, Issue 1, 1999, Pages 66-70

  Hirono, Nobutsugu ^a   Mori, Etsuro ^a   Yasuda, Minoru ^a   Imamura, Toru ^a   Shimomura, Tatsuo ^a   Hashimoto, Mamoru ^a   Tanimukai, Satoshi ^a   Kazui, Hiroaki ^a   Yamashita, Hikari ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; DISEASE DURATION; DISEASE SEVERITY; EDUCATION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; ONSET AGE; PRIORITY JOURNAL;

EID: 0032907475     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.11.1.66     Document Type: Article

References (33)

1. Cummings JL, Victoroff JI: Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3:140-158
2. Mega MS, Cummings JL, Fiorello T, et al: The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46:130-135
3. Ramachandran G, Marder K, Tang M, et al: A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996; 47:256-259
4. Murphy GM Jr, Taylor J, Tinklenberg JR, et al: The apolipoprotein E ε4 allele is associated with increased behavioral disturbance in Alzheimer's disease. Am J Geriatr Psychiatry 1997; 5:88-89
5. Lyketsos CG, Baker L, Warren A, et al: Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 1997; 9:64-67
6. Lopez OL, Kamboh MI, Becker JT, et al: The apolipoprotein E ε4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49:794-797
7. Holmes C, Levy R, McLoughlin DM, et al: Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61:580-583
8. Hirono N, Mori E, Yasuda M, et al: Factors associated with psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 64:648-652
9. Cantillon M, Harwood D, Barker W, et al: No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease. Biol Psychiatry 1997; 41:246-248
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC, American Psychiatric Association, 1994
11. McKhann G, Drachmnn D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944
12. Hughes CP, Berg L, Danziger WL, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
13. Sano M, Devanand DP, Richards M, et al: A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol 1995; 52: 961-966
14. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
15. Hirono N, Mori E, Ikejiri Y, et al: [Japanese version of the Neuropsychiatric Inventory: a scoring system for neuropsychiatric disturbances in dementia patients] (Japanese). No to Shinkei 1997; 49:266-271
16. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
17. Yasuda M, Maeda K, Shimada K, et al: Apolipoprotein E ε4 allele and gender difference in risk of Alzheimer's disease. Alzheimer's Research 1995; 1:77-81
18. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159
19. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923
20. Poirier J, Davignon J, Bouthillier D, et al: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342:697-699
21. Lucotte G, Turpin JC, Landais P: Apolipoprotein E-ε4 allele doses in late-onset Alzheimer's disease. Ann Neurol 1994; 36:681-682
22. Cummings JL: The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48(suppl 6):S10-S16
23. Levy-Lahad E, Bird TD: Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol 1996; 40:829-840
24. Yasuda M, Mori E, Kitagaki H, et al: Apolipoprotein E ε4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am J Psychiatry 1998; 155:779-784
25. Basun H, Grut M, Winblad B, et al: Apolipoprotein ε4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995; 183:32-34
26. Dal Forno G, Rasmusson X, Brandt J, et al: Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996; 53:345-350
27. Kurz A, Egensperger R, Haupt M, et al: Apolipoprotein E ε4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996; 47:440-443
28. Growdon JH, Locascio JJ, Corkin S, et al: Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996; 47:444-448
29. Murphy GM Jr, Taylor J, Kraemer HC, et al: No association between apolipoprotein E ε4 allele and rate of decline in Alzheimer's disease. Am J Psychiatry 1997; 154:603-608
30. Corder EH, Saunders AM, Strittmatter WJ, et al: Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995; 45:1323-1328
31. Norrman J, Brookes AJ, Yates C, et al: Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. Br J Psychiatry 1995; 167:533-536
32. Corder EH, Jelic V, Basun H, et al: No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol 1997; 54:273-277
33. Hirono N, Mori E, Yasuda M, et al: Lack of association of apolipoprotein E ε4 allele dose with cerebral glucose metabolism in Alzheimer's disease. Alzheimer Dis Assoc Disord (in press)